KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Shares Issued: 2012-2023

Historic Shares Issued for TherapeuticsMD (TXMD) over the last 7 years, with Dec 2023 value amounting to $2.0 million.

  • TherapeuticsMD's Shares Issued was N/A to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $35.1 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2023, which is 28.40% up from last year.
  • Per TherapeuticsMD's latest filing, its Shares Issued stood at $2.0 million for Q4 2023, which was up 200,300.00% from -$1,000 recorded in Q3 2023.
  • Over the past 5 years, TherapeuticsMD's Shares Issued peaked at $150.9 million during Q1 2021, and registered a low of -$1,000 during Q3 2023.
  • Its 2-year average for Shares Issued is $31.0 million, with a median of $1.6 million in 2021.
  • In the last 5 years, TherapeuticsMD's Shares Issued crashed by 99.99% in 2019 and then surged by 209,481.94% in 2021.
  • TherapeuticsMD's Shares Issued (Quarterly) stood at $76.9 million in 2019, then crashed by 59.14% to $31.4 million in 2020, then tumbled by 96.07% to $1.2 million in 2021, then reached $2.0 million in 2023.
  • Its Shares Issued stands at $2.0 million for Q4 2023, versus -$1,000 for Q3 2023 and $1.2 million for Q4 2021.